Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer

Overview of attention for article published in Journal for Immunotherapy of Cancer, September 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 30,147 followers.

#JITC Commentary: Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer https://t.co/UVd6WQm47k

22 Oct 2019

Reply Repost Favourite

RT @sitcancer: New #JITC Commentary: Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapi…

26 Sep 2019

Reply Repost Favourite

RT @sitcancer: New #JITC Commentary: Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapi…

26 Sep 2019

Reply Repost Favourite

New #JITC Commentary: Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer https://t.co/ZhDzzkTubQ

26 Sep 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.